Srinivasa Karra

Title: Innovations of Srinivasa Karra

Introduction

Srinivasa Karra is a notable inventor based in Pembrooke, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds for the selective degradation of extracellular proteins. With a total of seven patents to his name, his work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents are "Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins" and "ASGPR-binding compounds for the degradation of extracellular proteins." The first patent describes extracellular protein degraders and compositions that feature a potent asialoglycoprotein receptor (ASGPR) binding ligand. This ligand is bound to an extracellular protein targeting ligand, allowing for the selective degradation of target extracellular proteins, such as immunoglobulin, in vivo to treat disorders mediated by these proteins. The second patent outlines compounds and compositions that also utilize an ASGPR binding ligand, aimed at the selective degradation of target extracellular proteins in vivo for therapeutic purposes.

Career Highlights

Srinivasa Karra is currently associated with Avilar Therapeutics, Inc., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a strong focus on addressing medical challenges through advanced biotechnological methods.

Collaborations

Some of his notable coworkers include Mark George Saulnier and Jesse Jingyang Chen, who contribute to the collaborative efforts at Avilar Therapeutics, Inc. Their combined expertise enhances the research and development initiatives within the company.

Conclusion

Srinivasa Karra's contributions to biotechnology through his patents and work at Avilar Therapeutics, Inc. highlight his role as a leading inventor in the field. His innovative approaches to protein degradation are set to make a significant impact on medical treatments in the future.